TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04427384: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Sponsor: GT Medical Technologies, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 600 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$3,557,400

Rescue Site Savings

+$2,356,200

Unlock Full NCT04427384 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04427384 Rescue Dossier →